Skip to content
Search

Latest Stories

India adopts new drug-making standards in response to overseas deaths

India adopts new drug-making standards in response to overseas deaths

The new guidelines underscore the manufacturer's accountability for product quality  

Following overseas deaths linked to Indian-made drugs since 2022, India’s Union Ministry of Health and Family Welfare has recently revised rules under Schedule M of the Drugs and Cosmetics Rules, 1945. This mandates Indian pharmaceutical companies to comply with new manufacturing standards this year.


The updated guidelines require pharmaceutical companies to inform the licensing authority about drug recalls and report product defects, deterioration, or faulty production. Previously, there was no provision for notifying the licensing authority about drug recalls.

Emphasising the manufacturer's responsibility for product quality, the new guidelines ensure products are fit for intended use, comply with licensing requirements, and do not pose risks to patients.

“Manufacturers must market a finished product only after obtaining 'satisfactory results' from ingredient tests and retaining sufficient samples for batch testing or verification,” the Health Ministry said.

In August, the Health Ministry reported an absence of testing of incoming raw materials in inspections of 162 drug factories since December 2022. Fewer than a quarter of India's 8,500 small drug factories meet international drug manufacturing standards set by the World Health Organization (WHO). Small manufacturers have a six-month deadline for WHO-GMP certification, while large units have a 12-month deadline.

Good Manufacturing Practices (GMPs) are mandatory standards ensuring product quality through control over materials, methods, machines, processes, personnel, and facilities. First incorporated in Schedule M in 1988, GMPs were last amended in June 2005.

The updated Schedule M includes 13 parts, offering GMP guidelines tailored to specific pharmaceutical drug manufacturing requirements. The amendments introduce five new categories of drugs, including those containing hazardous substances.

India, a major exporter of medicines to low/middle-income countries, requires WHO GMP certification for its pharmaceutical products. Approximately 8,500 of the country's 10,500 manufacturing units fall under the MSME category, with around 2,000 MSME units holding WHO GMP certification.

Sudarshan Jain, secretary-general of the Indian Pharmaceutical Alliance, said, "The government's revision of Schedule M is a positive and significant milestone for the Indian pharmaceutical sector. This will elevate and update the quality standards of medicines, reinforcing the industry's reputation and improving patient outcomes."

"The revised regulations of Schedule M will ensure compliance with international quality standards, benefiting both patients and the industry by promoting the manufacturing of safe, effective, and high-quality drugs,” he added.

More For You

Lack of funding deters NI pharmacy contractors from expanding portfolio

W G Hamilton Pharmacy is the third pharmacy in Northern Ireland to be recently sold to first-time buyers.

Pharmacy ownership trends shift in Northern Ireland due to funding gap

An increasing number of pharmacies in Northern Ireland are being acquired by first-time buyers, as existing contractors and groups pull back from expanding their portfolios amid ongoing funding pressures, according to specialist business property adviser Christie & Co.

Among the most recent sales is W G Hamilton Pharmacy, a busy community pharmacy in Ballysillan, North Belfast.

Keep ReadingShow less
RPS backs Pharmacist Support "Gift in Wills" initiative

The ‘Gift in Wills’ initiative is delivered in partnership with Bequeathed.

Photo credit: gettyimages

Leave a legacy: RPS partners with Pharmacist Support to promote ‘Gift in Wills’

The Royal Pharmaceutical Society (RPS) has announced its support for the ‘Gift in Wills’ initiative run by Pharmacist Support, coinciding with the charity’s birthday celebrations today (Tuesday 15 April).

This collaboration allows RPS members to create a free will while also helping to safeguard the future of vital support services for the pharmacy profession.

Keep ReadingShow less
Pharmacist Support calls for birthday donations to meet rising demand for mental health services

More and more pharmacy professionals are reaching out for help, said Danielle Hunt.

Pharmacist Support's birthday appeal: Donate to address growing mental health demand

Pharmacist Support – the independent charity dedicated to the pharmacy profession – is celebrating 184 years of service with the launch of a special birthday donations appeal.

On 15 April, the charity is urging individuals and organisations across the sector to support its campaign to raise vital funds to meet the increasing demand for its mental health and wellbeing services.

Keep ReadingShow less
Prostate cancer: At-home saliva test could save NHS £500 million annually

PRS saliva test can identify prostate cancer that was missed by an MRI scan

Photo credit: gettyimages

Prostate cancer: Spit test better than blood test in spotting men at highest risk

A simple at-home spit test could help detect prostate cancer earlier, saving the NHS around £500 million a year, according to new research published in the New England Journal of Medicine.

Funded by the National Institute for Health and Care Research (NIHR), the study found that the DNA-based saliva test was more accurate than the current prostate-specific antigen (PSA) blood test in identifying men at risk of developing prostate cancer.

Keep ReadingShow less
RPS launches innovative new learning resources for members

With RPS Learn, pharmacists can develop a new skill or improve their understanding of practice or a clinical topic.

Gettyimages

RPS launches new learning resources to boost career development for members

The Royal Pharmaceutical Society (RPS) has launched a new online learning platform designed to support the practice, development and career advancement of its members.

The new platform, called RPS Learn, offers a diverse range of bite-size learning content, available on-demand, catering to all levels — from introductory to advanced and specialist —combining new content with RPS's renowned expertise in education and training to achieve excellence for learners.

Keep ReadingShow less